Younggeon Jin

Jin, Y., Ibrahim, D., Magness, S. T., & Blikslager, A. T. (2018). Knockout of ClC-2 reveals critical functions of adherens junctions in colonic homeostasis and tumorigenicity. American Journal of Physiology-Gastrointestinal and Liver Physiology, 315(6), G966–G979. https://doi.org/10.1152/ajpgi.00087.2018

Shin, J., & Ferguson, S. (2017). Exploring Product Solution Differences Due to Choice Model Selection in the Presence of Noncompensatory Decisions With Conjunctive Screening Rules. JOURNAL OF MECHANICAL DESIGN, 139(2). https://doi.org/10.1115/1.4035051

Jin, Y., & Blikslager, A. T. (2016). Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury. American Journal of Physiology-Cell Physiology, 311(6), C996–C1004. https://doi.org/10.1152/ajpcell.00113.2016

Kim, D. G., Jin, Y., Jin, J., Yang, H., Joo, K. M., Lee, W. S., … Nam, D.-H. (2015). Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis. MAbs, 7(6), 1195–1204. https://doi.org/10.1080/19420862.2015.1086854

Jin, Y., Pridgen, T. A., & Blikslager, A. T. (2015). Pharmaceutical Activation or Genetic Absence of ClC-2 Alters Tight Junctions During Experimental Colitis. Inflammatory Bowel Diseases, 21(12), 2747–2757. https://doi.org/10.1097/mib.0000000000000550

Lee, W. S., Pyun, B.-J., Kim, S.-W., Shim, S. R., Nam, J. R., Yoo, J. Y., … Yoo, J.-S. (2015). TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis. MAbs, 7(5), 957–968. https://doi.org/10.1080/19420862.2015.1045168

Jin, Y., Pridgen, T., & Blikslager, A. (2014). Tu2028 Lubiprostone reduces murine colitis principally in a ClC-2-dependent manner. Gastroenterology, 146(5), S-901. https://doi.org/10.1016/s0016-5085(14)63275-3

Lee, S. J., Seol, H. J., Lee, H. W., Kang, W. Y., Kang, B. G., Jin, J., … Nam, D.-H. (2013). Gene silencing of c-Met leads to brain metastasis inhibitory effects. Clin Exp Metastasis, 30(7), 845–854. https://doi.org/10.1007/s10585-013-9584-7

Jin, Y., Jin, J., Yang, H., Park, M., Lee, W. S., Kim, S.-W., … Nam, D.-H. (2011). Abstract 647: TTAC-0001, anti-VEGFR2/KDR monoclonal antibody, inhibits VEGFR signaling and tumor growth in preclinical models. Cancer Res, 71(8 Supplement), 647–647. https://doi.org/10.1158/1538-7445.am2011-647

Lee, J. C., Jin, Y., Jin, J., Kang, B. G., Nam, D.-H., Joo, K. M., & Cha, C. I. (2011). Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1 G93A ) transgenic amyotrophic lateral sclerosis (ALS) mice. Neurological Research, 33(1), 33–37. https://doi.org/10.1179/016164110x12807570509899

Jin, Y., Jin, J., Joo, K. M., Lee, S. J., Jo, M.-young, Kim, Y., & Nam, D.-H. (2010). Abstract LB-326: Synergistic therapeutic effects of cytokine-induced killer (CIK) cell and temozolomide against glioblastoma. Cancer Res, 70(8 Supplement), LB-326-LB-326. https://doi.org/10.1158/1538-7445.am10-lb-326